prof. dr. Triana Lobatón Ortega
- Work address
-
C. Heymanslaan 10, ingang 12 - verdieping 6
9000 Gent - Triana.LobatonOrtega@UGent.be
- ORCID iD
-
0000-0003-1817-7704
Show
Sort by
-
- Journal Article
- A1
- open access
Role of integrin expression in the prediction of response to vedolizumab : a prospective real‐life multicentre cohort study
-
Infliximab re-challenge : could it be an option in refractory IBD patients?
-
A randomized placebo controlled clinical trial with 5-hydroxytryptophan in patients with quiescent Inflammatory Bowel Disease and fatigue (Trp-IBD)
-
Gastroenteropancreatic neuroendocrine neoplasms in patients with inflammatory bowel fisease : an ECCO CONFER multicentre case series
-
- Journal Article
- A1
- open access
Efficacy of anti-TNF dosing interval lengthening in adolescents and young adults with inflammatory bowel disease in sustained remission (FREE-study) : protocol for a partially randomised patient preference trial
-
Safety of vedolizumab and ustekinumab in elderly IBD patients : a real-life multicentric cohort study
(2021) UNITED EUROPEAN GASTROENTEROLOGY JOURNAL. In United European Gastroenterology Journal 9(S1). p.554-555 -
Patient perspectives on the role of the IBD nurse and telemedicine during COVID-19 pandemic : results from a Belgian tertiary IBD unit
-
Gastroenteropancreatic neuroendocrine neoplasms in patients with inflammatory bowel disease : an ECCO CONFER multicentre case series
-
First results of the BELCOMID study : Belgian cohort study of COVID-19 in Immune Mediated Inflammatory Diseases (IMID)
-
The impact of vedolizumab and ustekinumab on arthropathy and arthralgia in IBD patients : a real-life multicentric cohort study